Fcγ Receptor I Alpha Chain (CD64) Expression in Macrophages Is Critical for the Onset of Meningitis by Escherichia coli K1 by Mittal, Rahul et al.
Fcc Receptor I Alpha Chain (CD64) Expression in
Macrophages Is Critical for the Onset of Meningitis by
Escherichia coli K1
Rahul Mittal
1., Sunil K. Sukumaran
1., Suresh K. Selvaraj
1, David G. Wooster
1, M. Madan Babu
2, Alan D.
Schreiber
3, J. Sjef Verbeek
4, Nemani V. Prasadarao
1,5*
1Division of Infectious Diseases, The Saban Research Institute, Childrens Hospital Los Angeles, Los Angeles, California, United States of America, 2Structural Studies
Division, Medical Research Council, Laboratory of Molecular Biology, Cambridge, United Kingdom, 3Hematology and Oncology Division, University of Pennsylvania
School of Medicine, Philadelphia, Pennsylvania, United States of America, 4Department of Human Genetics, University Medical Center, Leiden, Netherlands, 5Keck School
of Medicine, University of Southern California, Los Angeles, California, United States of America
Abstract
Neonatal meningitis due to Escherichia coli K1 is a serious illness with unchanged morbidity and mortality rates for the last
few decades. The lack of a comprehensive understanding of the mechanisms involved in the development of meningitis
contributes to this poor outcome. Here, we demonstrate that depletion of macrophages in newborn mice renders the
animals resistant to E. coli K1 induced meningitis. The entry of E. coli K1 into macrophages requires the interaction of outer
membrane protein A (OmpA) of E. coli K1 with the alpha chain of Fcc receptor I (FccRIa, CD64) for which IgG opsonization is
not necessary. Overexpression of full-length but not C-terminal truncated FccRIa in COS-1 cells permits E. coli K1 to enter the
cells. Moreover, OmpA binding to FccRIa prevents the recruitment of the c-chain and induces a different pattern of tyrosine
phosphorylation of macrophage proteins compared to IgG2a induced phosphorylation. Of note, FccRIa
2/2 mice are
resistant to E. coli infection due to accelerated clearance of bacteria from circulation, which in turn was the result of
increased expression of CR3 on macrophages. Reintroduction of human FccRIa in mouse FccRIa
2/2 macrophages in vitro
increased bacterial survival by suppressing the expression of CR3. Adoptive transfer of wild type macrophages into FccRIa
2/
2 mice restored susceptibility to E. coli infection. Together, these results show that the interaction of FccRI alpha chain with
OmpA plays a key role in the development of neonatal meningitis by E. coli K1.
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Introduction
Professional phagocytes, including neutrophils and macrophages
(MØ) express a specific set of phagocytic receptors that recognize,
bind to and mediate internalization of microbial pathogens [1,2,3].
Although MØ receptor-mediated phagocytosis generally leads to
the destruction of the pathogen, certain receptor-ligand interactions
allow for a permissive environment in which the pathogen can
thrive and even proliferate. MØ provide a barrier that pathogens
must overcome to adhere to and penetrate into tissues. Nonetheless,
diverse strategies are used by different bacterial pathogens to
subvert phagocytes. Escherichia coli K1 causes meningitis in neonates,
which remains a significant problem for the last few decades with
case fatality rates ranging from 5 to 40% of infected neonates
[4,5,6,7].Despite treatment with advanced antibiotics,upto 30%of
survivors exhibit neurological sequelae such as hearing impairment,
mental retardation, and hydrocephalus. Furthermore, due to the
emergence of antibiotic resistant strains, mortality rates may
significantly increase in future [8]. The crossing of the mucosal
epithelium and the invasion of small subepithelial blood vessels by
E. coli K1 represent critical early steps in the pathogenesis of
meningitis. During initial colonization, E. coli K1 encounters several
host defense mechanisms such as complement, neutrophils, and
MØ on its path to the blood-brain barrier (BBB). However, very
little is known about the mechanisms by which E. coli K1 finds a
niche to avoid these host defenses. Our previous studies demon-
strated that E. coli K1 evades complement attack by binding to the
complement pathway regulator C4bp via outer membrane protein
A (OmpA), which subsequently cleaves C3b and C4b complement
proteins [9,10]. In addition, lack of significant quantities of C9, a
terminal complement component necessary for the formation of the
membrane attack complex, in neonatal population gives an
additional opportunity for E. coli K1 to survive in the blood [10].
However, our studies have shown that an inoculum of .10
3 CFU/
ml of E. coli K1 is required to resist serum bactericidal activity [11],
indicating that the bacteria must take a refuge in certain cells to
survive and multiply during the initial stages of infection, when
fewer bacteria are present in the blood.
Despite the importance of MØ in innate and adaptive immunity,
the interaction of E. coli K1 with these cells is poorly defined. MØ
PLoS Pathogens | www.plospathogens.org 1 November 2010 | Volume 6 | Issue 11 | e1001203phagocytose a broad range of pathogens by recognizing pathogen-
associated molecular pattern (LPS and peptidoglycans) via pattern
recognition receptors (PRR), which include TLRs, the mannose
receptor and the scavenger receptor [12,13]. Opsonin-dependent
phagocytosis involves complement receptors and antibody-dependent
phagocytosis requires Fcc receptors. Studies from our lab have shown
that E. coli K1 enters and multiplies in both human and murine MØ,
either in the presence or absence of opsonization. OmpA expression is
critical for these processes [14]. Therefore, it is important to determine
whether E. coli OmpA interacts with any cell surface proteins of MØ
for entry. Numerous studies have shown that the expression of FccRIis
increased during septicemia and meningitis caused by a variety of
pathogens [15,16,17], although its importance in any of these
infections has not been explored. Fcc receptors (FccR) recognize the
Fc region of IgG and play a pivotal role in linking the cellular and
humoral arms of the immune response. FccR comprises a multigene
family divided into 3 classes (FccRI, II and III), which are defined by
their affinity for IgG [18,19,20,21,22,23]. FccRI is a transmembrane
receptor, which binds IgG with high affinity and induces the
association of the c-chain for signal transduction and triggering of
effector responses such as MØ phagocytosis [23]. The ligation of
FccRI with IgG also mediates antibody-dependant cellular cytotoxicity
induced transcription of cytokine genes and release of inflammatory
mediators [24]. The cytoplasmic domain of the c-chain contains an
immunoreceptor tyrosine activation motif (ITAM), which is necessary
for the signaling cascade of FccR s .T h ec y t o p l a s m i cd o m a i no fF c cRI
has been shown to modulate receptor function, although it does not
contain any recognized signaling motif [25,26]. In this study, we
examined the role of MØ and FccRI a-chain (FccRIa) in the
pathogenesis of neonatal E. coli K1 meningitis by depleting MØ from
newborn mice and utilizing a FccRIa
2/2knockout mouse model. Our
studies provide evidence of a role for a novel interaction between
FccRIa and OmpA in the onset of meningitis due to E. coli K1.
Results
MØ-depleted newborn mice are resistant to E. coli K1
induced meningitis
Our previous studies have shown that OmpA+ E. coli enters and
survives in human and mouse MØ [14]. To determine the role of
MØ in the pathogenesis of E. coli K1 induced meningitis, MØ were
depleted in newborn mice by the administration of carrageenan
[27,28]. MØ readily ingest carrageenan in contrast to lymphocytes,
which are not actively phagocytic and lack a well-developed
lysosomal complex. Due to its unique secondary and tertiary
structure, carrageenan is resistant to biochemical degradation by
lysosomal glycosidases. Carrageenan containing phagolysosomes
eventually rupture due to osmotic swelling. The consequent release
of hydrolytic enzymes into the cytosol causes irreversible damage
and eventual lysis of MØ [29]. Following three days of carrageenan
administration starting at day 1 after birth, the animals showed
.95% depletion of MØ from livers and spleens, as shown by flow
cytometry after staining with F4/80 antibody (5.33%60.4% before
and 0.17%60.1% after carrageenan treatment) (Figure 1A).
However, treatment with carrageenan did not affect B cells
(39.81%60.7% before and 40.19%60.9% after carrageenan
treatment), CD4+ T cells (17.56%60.5% before and 18.02%6
0.6% after carrageenan treatment), CD8+ T cells (2.11%60.4%
before and 2.53%60.3% after carrageenan treatment), DCs
(5.67%61.2% before and 6.09%60.9% after carrageenan treat-
ment), or PMNs (3.98%61.2% before and 4.13%61.4% after
carrageenan treatment) in spleens of MØ-depleted mice compared
with untreated mice (Figure S1). The MØ-depleted mice were then
infected with 10
3 CFU of E. coli K1 by intranasal instillation and
examinedforprogression ofthe diseaseaspreviouslydescribed[28].
Control animals (n=15 for each group) developed bacteremia at 6
h post-infection, which was increased to 5.5 log10 CFU per ml of
blood by 48 h (Figure 1B). In contrast, the MØ-depleted mice,
despite having a similar number of bacteria in the blood at 6 h,
clearedthese bacteria from the circulation by 48 h post-infection. In
agreement with the bacteremia levels, .90% of control mice
developed meningitis at 72 h after infection, whereas none of the
MØ-depleted animals showed signs of meningitis and all survived
beyond 7 days (Figure 1C). Determination of serum cytokine levels
at various times post-infection revealed that control animals
produced an initial burst of IL-10, which peaked at 12 h, and then
declined to basal levels by 48 h (Figure 1D). In contrast, the pro-
inflammatory cytokines, TNF-a,I F N - c,I L - 1 b, IL-6 and IL-12p70
only became detectable in the blood at 12 h post-infection and
peaked by 72 h (Figure 1D and Figure S2). Of note, although the
MØ-depleted mice had early production of pro-inflammatory
cytokines, their levels were significantly lower than those in the
control mice. In these mice, IL-10 levels progressively rose during
the initial stages of infection and peaked at 72 h at which time the
bacteria were completely cleared from the circulation (Figure 1D).
Histopathological examination of control mice infected with E.
coli K1 revealed marked infiltration of PMNs in the leptomenin-
geal and ventricular spaces (Figure 1E). The hippocampus was also
inflammed and there was apoptosis of neurons, as indicated by
pkynotic nuclei in Ammon’s horn. Acute hemorrhage and
inflammation was observed, most prominently in the white matter
of the brain. The cortex and molecular layer had increased
cellularity due to inflammatory exudates. The MØ-depleted mice,
however, did not reveal such pathological changes. Blood brain
barrier (BBB) leakage is the hallmark of neonatal meningitis.
Therefore we used the Evans blue extravasation method to
quantify BBB leakage in both the control and MØ-depleted mice
[28]. The dye was injected intraperitoneally at 68 h post-infection
and after four hours, the brains were removed and Evans blue
concentration determined. A marked increase in the permeability
of the BBB was observed in infected WT animals, which was
significantly reduced in MØ-depleted mice, (p,0.001 by student’s
t test) (Figure 1F). Furthermore, the number of E. coli K1 entering
the brain was approximately 6.0 log10 CFU in control animals,
Author Summary
Escherichia coli K1 is the most common cause of meningitis
in premature infants; the mortality rate of this disease
ranges from 5% to 30%. A better understanding of the
pathogenesis of E. coli K1 meningitis is needed to develop
new preventative strategies. We have shown that outer
membrane protein A (OmpA) of E. coli K1, independent of
antibody opsonization, is critical for bacterial entrance and
survival within macrophages. Using a newborn mouse
model, we found that depletion of macrophages renders
the animals resistant to E. coli K1 induced meningitis.
OmpA binds to a-chain of Fcc-receptor I (FccRIa) in
macrophages, but does not induce expected gamma chain
association and signaling. FccRIa knockout mice are
resistant to E. coli K1 infection because their macrophages
express more CR3 and are thus able to kill bacteria with
greater efficiency, preventing the development of high-
grade bacteremia, a pre-requisite for the onset of
meningitis. These novel observations demonstrate that
inhibiting OmpA binding to FccRIa is a promising
therapeutic target for treatment or prevention of neonatal
meningitis.
Role of FccRI Alpha Chain in E. coli K1 Meningitis
PLoS Pathogens | www.plospathogens.org 2 November 2010 | Volume 6 | Issue 11 | e1001203Figure 1. Depletion of MØ in newborn mice prevented the occurrence of meningitis by E. coli K1. Newborn mice were administered a-
carrageenan once a day for three days after birth. Spleens and livers were harvested, homogenized and the cells in the homogenates were subjected
to flow cytometry after staining with F4/80 antibodies. Cells from untreated animals and those stained with isotype-matched antibodies were used as
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PLoS Pathogens | www.plospathogens.org 3 November 2010 | Volume 6 | Issue 11 | e1001203whereas the brains of the MØ-depleted animals contained very
few bacteria (Figure 1G). These results demonstrate that MØ may
be important for E. coli K1 to reach a required level of bacteremia,
which is critical for the establishment of neonatal meningitis.
OmpA interaction with FccRIa is requisite for E. coli K1
binding to, and entry into, MØ
Our previous studies have shown that OmpA+ E. coli binds and
enters MØ in vitro irrespective of opsonization status of the bacteria
[14]. OmpA2 E. coli, although entered in lower numbers but failed
to survive inside MØ. This indicates that OmpA mediated entry
into MØ enables OmpA+ E. coli K1 to resist the normal
antimicrobial mechanisms of MØ. Therefore, to understand the
nature of the macrophage surface structures that interact with E. coli
K1, biotin-labeled cell surface proteins of THP-1 cells differentiated
into MØ (THP-M) and RAW 264.7 cells were incubated with
OmpA+ E. coli, OmpA2 E. coli or a laboratory E. coli HB101.
Bound proteinswerethen released and analyzedbywesternblotting
with streptavidin peroxidase. A small number of proteins bound to
all the bacteria from both the cells. However, OmpA+ E. coli
prominently bound to the 110 and 70 kDa proteins from both
THP-M and RAW 264.7 cells, whereas OmpA2 E coli bound only
to the 110 kDa protein (Figure 2A). Although some proteins bound
to HB101 were of similar molecular mass to those bound to
OmpA+/OmpA2 E. coli, other proteins showed different binding
patterns. Based on their molecular masses, we speculated that the
proteins binding to E. coli K1 could be Toll like receptor-4
(110 kDa) and FccRIa (CD64, 72 kDa). Since OmpA+ E. coli
specifically bound to the 70 kDa protein in contrast to OmpA2 E.
coli, the blots were reprobed with an anti-FccRI antibody, which
reacted with the 70 kDa protein, suggesting that OmpA+ E. coli
binds to FccRIa. Of note, treating the bacteria with 40% pooled
human serum did not alter the binding, indicating that opsonization
with complement and/or with non-specific antibody did not alter
bacterial interaction with macrophage surface proteins.
Next, we used blocking antibodies to determine the contribution of
OmpA-FccRIa interaction in E. coli entry into MØ. OmpA+ E. coli
was incubated with Fab fragments of anti-OmpA antibody
(polyclonal) prior to addition to MØ. In other experiments, the
RAW 264.7 cells were pre-treated with antibodies to FccRI, CR3,
TLR2, TLR4 or the mannose receptor prior to addition of OmpA+
E. coli. Isotype matched antibodies or anti-S-fimbria antibodies were
used as controls. Both anti-OmpA and anti-FccRI antibodies
reduced the number of bound and intracellular E. coli K1 by
,80%, whereas other antibodies showed no significant inhibition
(Figure 2B). To verify that the anti-FccRI antibody actually inhibited
FccRI–mediated phagocytosis, the effect of this antibody on the entry
of zymosan coated with fluorescent-labeled IgG2a that occurs via
FccRI was also determined. The internalized zymosan particles were
counted per 100 cells after quenching the external fluorescence by
Trypan Blue [30]. As predicted, anti-FccRI antibodies significantly
inhibited the entry of opsonized zymosan (Figure 2C).
MØ pretreated with the anti-FccRI antibody were also infected
with Group B streptococcus (GBS) pre-treated with C8-deficient
serum (for deposition of C3 and to avoid bacterial killing by
serum), which is known to enter MØ through the CR3 receptor
[31,32,33]. The internalization of GBS, however, was not affected
by pretreatment with anti-FccRI antibody, suggesting that it did
not interfere with CR3 receptor function in MØ (Figure 2D).
However, as expected, anti-CR3 antibodies significantly blocked
the binding and entry of GBS into RAW 264.7 cells. To further
confirm the role of OmpA interaction with MØ in E. coli entry into
MØ, OmpA was purified from OmpA+ E. coli and reconstituted
into liposomes as previously described [34], which were used to
pre-treat RAW 264.7 cells prior to adding the bacteria (Figure 2E).
The liposomes containing OmpA blocked both binding and
intracellular survival of E. coli K1 by approximately 50%, whereas
liposomes containing outer membrane proteins from OmpA2 E.
coli did not show such inhibition. Increasing concentrations of
OmpA liposomes showed no further increase in the inhibition,
indicating that the structure of OmpA in liposomes may not be
optimal to that of OmpA on E. coli K1 to bind to FccRIa.
The fate of OmpA+ E. coli after phagocytosis by RAW 264.7
cells was examined by immunocytochemistry after differential
staining. Extracellular bacteria were stained with FITC labeled
secondary antibody (green) and the intracellular bacteria were
stained with a TRITC labeled secondary antibody (red) after
incubation with primary anti-S-fimbria antibody. As shown in
Figure 2F, a number of OmpA+ E. coli bound to RAW 264.7 cells,
whereas very few OmpA2 E. coli bound at 30 min post-infection.
Analysis of intracellular bacteria over time revealed that OmpA+
E. coli multiplied, whereas OmpA2 E. coli were degraded inside
the cells. Collectively, these studies suggest that the OmpA of E.
coli K1 interacts with regions of FccRIa similar to those involved in
the binding of Fc and that this interaction enables the organism to
enter MØ. In addition, the data suggest that other receptors that
recognize pathogen-associated molecules may not play a signifi-
cant role in MØ binding and entry of E. coli K1. However, entry
through other receptors in the absence of OmpA-FccRIa
interaction renders the bacteria susceptible to macrophage killing.
FccRIa gene silencing by RNA interference abolishes E.
coli K1 binding to and entry into MØ
To confirm the role of FccRIa in OmpA+ E. coli entry of MØ,
short hairpin RNA (shRNA) sequences for murine FccRIa and
CR3 in pGeneClip Neomycin vectors were used to transfect RAW
controls (A). The MØ-depleted animals were infected with 10
3 CFU of E. coli K1 by intranasal instillation and blood was collected at different post-
infection times. Various dilutions of the blood were plated on agar containing rifampicin (B). Cerebrospinal fluid was collected from the same animals
aseptically by cisternal puncture and inoculated into LB broth containing antibiotics (C). Blood collected from these animals was also used to measure
the presence of TNF-a or IL-10 by ELISA (D). At 72 h post-infection, animals were sacrificed due to a moribund situation for ethical reasons, and the
brains were harvested, fixed, paraffin sections prepared and stained with Hematoxylin and Eosin (E). Neutrophil infiltration (black arrow) was
observed in the cortex and meninges in brains of WT mice along with apoptosis of neurons indicated by perinuclear halo (yellow arrows). White
matter showed increased cellularity due to inflammatory exudates. Pkynotic nuclei (yellow arrows) and inflammatory cells (black arrow) were
observed in the hippocampus, suggesting apoptosis of neurons. In contrast, no such pathological changes were seen in the brains of MØ-depleted
mice. In some experiments, the animals were injected intraperitoneally with Evans blue at 68 h post-infection. The animals were sacrificed at 72 h the
brains were harvested, then homogenized and the concentration of Evans blue determined (F). Brain homogenates from uninfected animals were
used as controls. Half of the brain from each animal was homogenized and the presence of E. coli K1 determined by plating the homogenates on
antibiotic containing agar (G). The data represent mean values 6 SE of three separate experiments with a total of 15 animals per group.
Histopathology is from one animal that is representative of similar results from the rest of the experimental group. Blood brain barrier leakage and
the bacterial burden in MØ-depleted animals were statistically different when compared with the untreated and infected animals, *p,0.001 by
Student’s t test. Scale bars, 20 mM.
doi:10.1371/journal.ppat.1001203.g001
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PLoS Pathogens | www.plospathogens.org 4 November 2010 | Volume 6 | Issue 11 | e1001203Figure 2. OmpA interaction with FccRIa is necessary for binding to, and entry of, E. coli K1 in RAW 264.7 cells. (A) The surface proteins
of RAW 264.7 cells and THP-1 differentiated into macrophages (THP-M) were labeled with NHS-LC-Biotin and the membrane proteins prepared.
OmpA+ or OmpA2 E. coli, with or without treatment with 40% pooled human serum for 10 min, or HB101 were incubated with 2 mg of biotinylated
proteins for 1 h, washed, the bound proteins released, and subjected to SDS-PAGE. The proteins were then transferred to a nitrocellulose and
immunoblotted with streptavidin peroxidase. The blots were stripped and reprobed with anti-FccRI antibody. (B) RAW 264.7 cells were incubated
with various antibodies prior to the addition of E. coli K1. Similarly, OmpA+ E. coli were incubated with anti-OmpA antibodies for 1 h on ice prior to
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and expression was verified by RT-PCR and flow cytometry,
respectively. The respective shRNA suppressed the transcription of
FccRIa and CR3 considerably, but had no effect on GAPDH,
TLR2 or TLR4 mRNA transcript levels (Figure 3A). On par with
changes in transcription levels, the surface expression of FccRIa
and CR3 was significantly reduced, while TLR2 and TLR4
expression was unaltered (Figure 3B). There was .90% reduction
in the OmpA+ E. coli phagocytosed by FccRIa-shRNA/RAW cells
compared to control or CR3-shRNA/RAW cells (p,0.001 by
two-tailed t test) (Figure 3C). This reduction was due to inefficient
binding of E. coli K1 to these cells, as less than 30% of bacteria
were bound by the FccRIa-shRNA/RAW cells compared to non-
transfected or control-shRNA transfected cells. In contrast, both
binding and intracellular survival of GBS were not affected in
FccRIa-shRNA/RAW cells, whereas CR3-shRNA transfection
caused significant reduction in both of these processes (Figure 3D).
Immunocytochemistry of E. coli K1 infected FccRIa-shRNA/
RAW cells revealed that very few cells ingested bacteria and were
killed within 2 h post-infection (Figure 3E, fragmented bacteria).
However, E. coli K1 entered and replicated in CR3-shRNA/RAW
cells similar to control RAW cells. Comparable results were also
obtained with THP-M cells transfected with shRNA specific to
human FccRI (data not shown). To further confirm that lack of
FccRIa expression rendered bacteria susceptible to macrophage
killing, FccRIa-shRNA/RAW cells infected with E. coli K1 were
examined by transmission electron microscopy. Although few
numbers of FccRIa-shRNA/RAW cells engulfed E. coli K1,
several of them were either degraded or in the process of
degradation by 1 h post-infection and were completely killed by
8 h post-infection (Figure 3F). In contrast, CR3-shRNA/RAW
cells showed intact bacteria in endosomes undergoing significant
multiplication by 8 h post-infection. Taken together these results
demonstrate that OmpA-FccRIa interaction is critical for E. coli
K1 to bind to, enter and survive in MØ.
COS-1 cells expressing FccRIa are susceptible to E. coli K1
infection
The activation of FccRI in phagocytic cells by the binding of the
Fc region of IgG requires the association of FccRIa with the IgG
c-chain [19]. To examine whether c-chain association with FccRI
is also necessary for E. coli K1 invasion, COS-1 cells were
transfected with pcDNA3 plasmids containing Myc-tagged human
FccRIa (Myc-hFccRIa), C-terminal truncated Myc-hFccRIa
which lacks the cytoplasmic tail (CT) or Myc-hFccRII. Expression
of these proteins was verified by Western blotting using the anti-
Myc antibodies (Figure 4A) and flow cytometry (Figure 4B).
OmpA+ E. coli binding to, and invasion of, hFccRIa
+/COS-1 cells
was significantly greater compared to that of mock-transfected
cells (Figure 4C). OmpA2 E. coli showed very negligible binding
to, and invasion into, both FccRIa transfected and mock-
transfected COS-1 cells (data not shown). The invasion of E. coli
K1 into Myc-hFccRIa-CT/COS-1 cells was significantly reduced,
although the binding of bacteria to these cells was decreased by
only 30% compared to Myc-hFccRIa
+/COS-1 cells. In contrast,
overexpression of FccRII did not increase E. coli binding to, or
invasion of, COS-1 cells. These data suggest that FccRIa acts as
receptor for OmpA mediated entry of E. coli K1 into COS-1 cells
and that the C-terminal portion is required for this invasion.
Next, to examine whether FccRIa interacts with OmpA,
recombinant hFccRIa (rhFccRIa) was purified by Myc-affinity
column chromatography from COS-1 cells and incubated with
OmpA+ or OmpA2 E. coli. The bound proteins were released and
subjected to Western blotting with antibodies to Myc or FccRI.
The purified rhFccRIa bound to OmpA+ E. coli but not to
OmpA2 E. coli, whereas BSA, used as a control, did not interact
with the bacteria (Figure 4D). rhFccRIa used to pre-treat bacteria
prior to adding them to COS-1 monolayers in the invasion assays
resulted in much more significant inhibition of E. coli K1 binding
to, and entry into the cells in a dose dependent manner when
compared to the BSA control (Figure 4E). These results suggest
that the alpha chain of FccRI is sufficient for E. coli K1 to bind to,
and invade, COS-1 cells.
OmpA of E. coli K1 binds to FccRIa and induces a distinct
signaling pattern
One important question to address in these studies is how
OmpA of E. coli K1 binds to FccRIa at the same region as the Fc-
portion of IgG in the context of whole blood. Generally, specific or
even non-specific IgG in circulation binds invading bacteria and
thereby presents the pathogen to FccR receptors on MØ.
Therefore, it is possible that OmpA+ E. coli may be displacing
IgG for binding to FccRI. We tested this hypothesis by performing
two different competitive binding experiments. First, OmpA2 E.
coli were coated with anti-S-fimbria antibody and added to
FccRIa
+/COS-1 cells treated with cytochalasin D to prevent
internalization. The cells were washed and then various quantities
of OmpA+ E. coli were added and incubated for 10 min. After
washing the monolayers, the number of OmpA2 E. coli that
remained bound to COS-1 cells were determined by plating on
agar containing tetracycline (OmpA+ E. coli is sensitive to
tetracycline). As shown in Figure 5A, IgG2a opsonized OmpA2
E. coli bound COS-1 cells in significantly greater numbers
compared to unopsonized bacteria and progressively more
bacteria were released from the cells as more OmpA+ E. coli
were added to the wells. In contrast, OmpA2 E. coli could not
displace bound OmpA2 E. coli. In separate experiments,
peritoneal MØ were incubated with FITC-IgG2a (1 mg) for 1 h
in the presence of cytochalasin D, washed and then various
quantities of OmpA+ E. coli or OmpA2 E. coli were added. The
cells were incubated for 10 min, washed and the amount of FITC-
IgG that remained bound to the MØ was determined by flow
cytometry. As shown in Figure 5B, the amount of FITC-IgG2a
bound to peritoneal MØ was decreased when OmpA+ E. coli were
added, whereas addition of OmpA2 E. coli had no effect. These
adding to MØ. Isotype-matched antibodies or anti-S-fimbria antibodies were used as controls. Bound and intracellular bacteria were determined by
the gentamicin protection assay as described in Materials and Methods. Bound or intracellular bacteria of untreated cells were taken as 100%. (C and
D) Similar studies were also performed with Zymosan coated with IgG2a and Group B streptococcus. Isotype-matched antibodies or anti-capsular
antibodies were used as controls. (E) Liposomes containing OmpA or outer membrane proteins of OmpA2 E. coli were incubated with RAW 264.7
cells for 30 min prior to adding the bacteria. Relative total cell bound and intracellular bacteria (by gentamicin protection assay) were determined. (F)
RAW 264.7 cells were infected with OmpA+ or OmpA2 E. coli for various time points, washed, fixed and differentially stained for extracellular and
intracellular bacteria using anti-S-fimbria antibodies. The extracellular bacteria were stained with FITC-coupled secondary antibodies (Green) while
the intracellular bacteria were stained with Cy3-coupled secondary antibodies (Red). Scale bars, 10 mM. Data shown are mean values 6 SD of three
separate experiments performed in triplicate. The reduction in bound or invaded bacteria was statistically significant compared with control
untreated and infected cells, *p,0.001 by Student’s t test.
doi:10.1371/journal.ppat.1001203.g002
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PLoS Pathogens | www.plospathogens.org 6 November 2010 | Volume 6 | Issue 11 | e1001203Figure 3. Suppression of FccRIa expression using shRNA prevents E. coli K1 entry into RAW 264.7 cells. (A) RAW 264.7 cells were
transfected with plasmids containing shRNA to FccRIa or CR3, total RNA was isolated and subjected to RT-PCR using specific primers. GAPDH primers
were used as internal controls. (B) FccRIa
2/2 and CR3
2/RAW cells were further subjected to flow cytometry using antibodies to FccRI, CR3, TLR2 and
TLR4. Mean fluorescence intensities were plotted after subtracting the values of isotype-matched controls. (C and D) Total cell bound and intracellular
bacteria (measured by gentamicin protection assay) were determined after infecting FccRIa
2/2 and CR3
2/RAW cells with E. coli K1 or Group B
streptococcus. E. coli K1 or GBS that were bound or intracellular in control cells were taken as 100%. (E) Immunocytochemistry of E. coli K1 entered into
FccRIa
2/2 and CR3
2/RAW cells after differential staining as described in Materials and Methods. Scale bars, 10 mM. (F) FccRI
2/2 and CR3
2/RAW cells
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OmpA can displace bound IgG2a.
Binding to the c-chain of FccRIa is crucial for inducing the anti-
microbial activity of MØ [20]. Since OmpA binding to FccRIa
prevented the killing of the bacteria, we hypothesize that E. coli K1
interaction with FccRIa avoids the association of the c-chain.
Consistent with this assumption, OmpA+ E. coli interaction with
MØ in the presence or absence of IgG2a opsonization induced far
less c-chain association with FccRIa in comparison to OmpA2 E.
coli, as shown by immunoprecipitation studies (Figure 5C).
Similarly, OmpA+ E. coli induced a distinct tyrosine phosphory-
lation pattern of macrophage cytoplasmic proteins compared to
OmpA2 E. coli opsonized with IgG2a (Figure 5D). Taken
together, these studies suggest that the interaction of E. coli K1
with FccRIa can displace the bound IgG2a, which is mediated by
OmpA. They also indicate that OmpA-FccRI interaction induces
novel signaling patterns, which may abrogate the normal
antimicrobial response of these cells.
FccRIa
2/2 mice are resistant to E. coli K1 infection and do
not develop high degree of bacteremia
To confirm the role of FccRIa in the pathogenesis of E. coli K1
meningitis, FccRIa
2/2 mice were used for infection studies. MØ
isolated from FccRIa
2/2 mice did not express FccRIa but had
unchanged expression of other FccRs, TLRs, mannose receptor
and CR3 were unchanged compared to normal littermates (data
not shown). The newborn animals were intranasally infected with
E. coli K1 and examined for disease progression. Of note, the
FccRIa
2/2 animals did not develop bacteremia even at a 100 fold
higher infectious dose, even though E. coli K1 entered the
circulation within two hours of infection (Figure S3A). In contrast,
wild type (WT) animals showed 7.0 log10 CFU of E. coli K1 in
blood at 72 h post-infection (Figure 6A). The FccRIa
2/2 mice did
not develop meningitis even when infected with a 100-fold greater
inoculum (data not shown). These mice did not show any signs of
meningitis even after 7 days of infection, whereas 90% of WT mice
showed positive CSF cultures by 72 h post-infection (Figure 6B).
Cytokine analysis in the sera of these animals demonstrated that
infected WT animals generated significant amounts of TNF-a, IL-
1b, IL-6, IFN-c and IL-12, but FccRIa
2/2 mice did not
(Figure 6C and Figure S3B–D). On the other hand, IL-10
production peaked at 24 h post-infection and subsequently
returned to basal levels in WT mice, whereas FccRIa
2/2 showed
increased IL-10 production at 72 h post infection (Figure 6D). We
next examined blood-brain barrier leakage in FccRIa
2/2 mice.
Infection with E. coli K1 caused no leakage in FccRIa
2/2 mice,
whereas WT animals had significant leakage of Evans blue dye
(Figure 6E). Furthermore, no bacterial colonies were detected in
the brains of FccRIa
2/2 mice, while WT animals had a high
bacterial load (Figure 6F). Similarly, the pathology of the brains
from FccRIa
2/2 mice revealed no infiltration of neutrophils,
neuronal damage or gliosis, which are the characteristic
pathological features of E. coli K1 meningitis observed in WT
bacteria infected mice (Figure 6G). In contrast, infection of
FccRIa
2/2 mice with GBS resulted in significant bacteremia and
development of meningitis (Figure S4A-C). Together these results
suggest that FccRIa expression is critical for E. coli K1 to achieve
high-grade bacteremia and for subsequent development of
meningitis in newborn mice.
FccRIa
2/2 MØ exhibit greater expression of CR3 and
TLR4 and produce lower levels of inducible nitric oxide
Our studies have shown that MØ isolated from E. coli K1
infected mice exhibit increased expression of FccRI and TLR2, as
well as increased production of nitric oxide (NO) due to iNOS
activation [28]. We also observed that upregulation of CR3
expression on MØ led to enhanced killing of E. coli K1, whereas
this effect was completely abrogated in CR3 siRNA transfected
MØ in vitro. Other investigators have also demonstrated that CR3,
TLR2 and TLR4 play important roles in the phagocytic ability of
MØ [35-42]. Therefore, we examined whether the inability of E.
coli K1 to survive in FccRIa
2/2 mice was due to altered
expression of surface receptors using flow cytometry. Peritoneal
MØ isolated from infected FccRIa
2/2 mice exhibited increased
expression of CR3 and TLR4, but lower expression of TLR2
(Figure 7A). These cells also produced lower or negligible
quantities of inducible NO upon challenge with E. coli K1,
whereas MØ from WT mice generated six-fold higher amounts of
NO at 6 h post-infection (Figure 7B). Furthermore, E. coli K1
binding to, and entry into, bone marrow-derived MØ (BMDMs)
from FccRIa
2/2 mice were significantly lower compared to WT
MØ (Figure 7C and D). Some bacteria entered FccRIa
2/2
BMDMs, but they were killed within a short period of time as
determined by immunocytochemistry (data not shown). To
substantiate the role of FccRI in E. coli K1 entry, FccRIa
2/2
BMDMs were transfected with hFccRIa, FccRIa-CT or FccRII
and then used for binding and invasion assays. As shown in
Figure 7C, E. coli K1 binding to FccRIa
2/2BMDM/FccRIa and
FccRIa
2/2BMDM/FccRIa-CT increased significantly compared
to FccRIa
2/2BMDMs and FccRIa
2/2BMDM/FccRII. Howev-
er, entry was limited to binding to FccRIa
2/2BMDM/FccRIa
cells only. These results suggest that FccRIa expression is critical
for E. coli K1 binding to, and entry into, MØ and that the C-
terminal domain plays a significant role for the entry. FccRIa
2/2
BMDM transfected with a FccRIa construct exhibited decreased
expression of TLR4 and CR3 and increased expression of FccRI
and TLR2 in comparison with FccRIa
2/2BMDM after challenge
with E. coli K1 (p,0.01) (Figure 7E). Transfection with FccRIa-
CT, however, resulted in only a partial increase or decrease of
these surface molecules. In contrast, FccRIa
2/2BMDM trans-
fected with FccRII showed basal level expression of these
molecules. Confirming the requirement of FccRIa interaction
with E. coli K1 to induce NO production, FccRIa
2/2BMDM/
FccRIa cells generated greater quantities of NO by 6 h post-
infection as compared to FccRI
2/2BMDM/FccRI-CT and
FccRI
2/2BMDM/FccRII cells (Figure 7F). Taken together, these
data suggest that FccRIa interaction with OmpA of E. coli K1 is
necessary for suppression of CR3 and TLR4 expression and to
enhance the expression of FccRI and TLR2, and maximal NO
production.
FccRIa
2/2 mice reconstituted with FccRIa
+/+ MØ are
susceptible to E. coli K1 meningitis
To confirm the role of FccRIa expression on MØ in the
pathogenesis of E. coli K1 meningitis, FccRIa
2/2 mice were
were infected with E. coli K1 for varying periods, fixed and subjected to transmission electron microscopy as described in Materials and Methods.
Photomicrographs at 1 h and 8 h post-infection are shown and arrows indicate vacuoles containing bacteria or empty vacuoles. Invasion
experiments were performed in triplicate and were independently done three times. Data represent mean 6 SD and the decrease in bound or
intracellular bacteria was statistically significant when compared with control shRNA/RAW 264.7cells, *p,0.001 by Student’s t test. Scale Bars 1.0 mM.
doi:10.1371/journal.ppat.1001203.g003
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PLoS Pathogens | www.plospathogens.org 8 November 2010 | Volume 6 | Issue 11 | e1001203Figure 4. FccRIa expression is sufficient to facilitate E. coli K1 invasion of COS-1 cells. COS-1 cells were transfected with plasmids
containing FccRIa, FccRI-CT or FccRII and the expression of the recombinant proteins was determined by Western blotting (A) from total cell lysates
or by flow cytometry (B) using anti-Myc antibody. COS-1 cells transfected with pcDNA3 were used as a control (Mock). E. coli K1 binding to, and
invasion of, transfected COS-1 cells were performed as described in Materials and Methods (C). Purified Myc-FccRIa or BSA (control) was incubated
with OmpA+ or OmpA2 E. coli for 1 h on ice. Bacteria were washed, the bound proteins were released and were subjected to SDS-PAGE. The proteins
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+/+ or FccRIa
2/2 MØ and then
infected with E. coli K1. FccRIa
2/2 mice that received
FccRIa
+/+ MØ showed higher blood bacterial numbers compared
with animals replenished with FccRIa
2/2 MØ (Figure 8A). 94%
of CSF cultures were positive for E. coli K1 in FccRIa
+/+ MØ
reconstituted mice, whereas all cultures were sterile in animals that
received FccRIa
2/2 MØ (Figure 8B). BBB disruption was
significant in FccRIa
+/+ MØ-replenished animals compared to
FccRIa
2/2 MØ reconstituted mice (Figure 8C). Higher numbers
of bacteria were also recovered from the brains of mice
replenished with FccRIa
+/+ MØ compared to animals those
received FccRIa
2/2 MØ (Figure 8D). These results confirm that
FccRIa expression on MØ is critical for the onset of E. coli K1
meningitis.
Discussion
The host response to infection starts with the identification of
invading microorganisms via innate immune surveillance systems
[43]. Nonetheless bacterial pathogens utilize very effective
mechanisms to avoid host defenses in order to promote successful
replication and dissemination [44]. MØ provide an important
innate and adaptive immune coverage in the host, although their
importance in E. coli K1 meningitis is unexplored. In the present
study, we demonstrate that the expression of FccRIa-chain in MØ
is critical for the survival of E. coli K1 inside these immune cells by
using MØ-depleted and FccRIa
2/2 mice. It is tempting to
speculate that the ability of E. coli K1 to survive inside MØ might
enable these bacteria to infect the central nervous system via a
‘‘Trojan horse’’ mechanism. Pathogens that naturally infect the
central nervous system, such as Brucella, Listeria, and Mycobacterium,
have been demonstrated to use this mode of entry [45,46]. We
observed that the interaction of OmpA with FccRIa in MØ is
critical for bacterial binding to, entry into, and subsequent survival
in these cells. Generally various FccRs recognize microbes coated
with either specific or non-specific antibodies. However a select
number of microbes have developed methods to avoid this
recognition. Protein A of S. aureus is known to bind to the Fc
portion of the antibodies so that it avoids interacting with FccRI,
whereas most other microbes either downregulate phagocytic
mechanisms or avoid phagocytosis entirely [47,48]. This study
therefore depicts the first evidence that a bacterial protein binds
directly to FccRIa to divert anti-microbicidal mechanisms.
Our competitive inhibition studies demonstrated that OmpA
interacts with FccRIa and can displace the binding of Fc portion
of IgG. Therefore, it is possible that the bacteria in circulation,
despite being coated with non-specific IgG, interact with MØ via
FccRIa for binding to and entering the cells for subsequent
multiplication. OmpA2 E. coli could not survive in MØ,
suggesting that the interaction of OmpA with FccRIa induces
survival strategies or suppresses anti-microbial pathways in MØ.
However, OmpA2 E. coli has been shown to express reduced
levels of type 1 fimbriae and susceptible to chemical stresses
[49,50]. Therefore, it is possible that OmpA2 E. coli could be less
capable of dealing with macrophage-induced stresses. Listeria,
Shigella, and Rickettsia escape from the phagosome to the cytosol to
avoid destruction in phagolysosomes [51]. Other pathogens
interfere with the normal biogenesis of phagolysosomes, thus
leading to the formation of replicative vacuoles [52,53]. Since E.
coli K1 continue to multiply inside phagosomes, one can speculate
that phagosomes containing OmpA+ E. coli avoid lysosomal fusion
by blocking phagosome maturation. The receptors expressed on
the surface of MØ play a decisive role in the course of infection,
whether pathogens are killed or the MØ machinery is taken over
by the microbes [54]. Receptors like TLR2, TLR4 and CR3 have
been implicated in the phagocytic ability of MØ [55,56,57].
Downregulation of CR3 expression on the surface of MØ has
been associated with the decrease in the phagocytosis of pathogens
and hence survival inside MØ [58]. TLR2 expression has been
shown to prolong survival of Staphylococcus aureus inside phagosomes
in MØ, which may be a strategy adopted by this pathogen to
evade innate immunity. On par with this concept, TLR2 or
MyD88 KO mice have been demonstrated to be resistant to sepsis,
indicating that TLR2 mediated signaling is playing an important
role in the survival of bacterial pathogens [59]. Activation of MØ
through TLR4 has been shown to direct the induction of Th1 and
Th-17 cells, which mediate protective cellular immunity to
Bordetella pertussis by enhancing the bactericidal activity of MØ
[60]. It is still to be determined whether TLR2 expression upon E.
coli K1 infection has any role in the pathogenesis of meningitis.
We recently demonstrated that iNOS
2/2 mice and aminogua-
nidine (iNOS specific inhibitor) treated MØ showed enhanced
expression of CR3 and TLR4 and very low levels of TLR2 and
FccRI, indicating that iNOS suppression results in decreased
expression of FccRI [28]. In agreement with these studies, we
showed here that lack of FccRI in MØ prevented the production
of inducible NO and increased the expression of CR3 and TLR4,
indicating that OmpA-FccRIa interaction is critical for manipu-
lating the surface expression of CR3 and TLRs in MØ. Our
current results indicate that in E. coli K1 pathogenesis, FccRI
interaction with OmpA enhances the expression of TLR2, which
in turn can be utilized by the bacteria as a receptor to modulate
the efficiency of phagosome formation. Alternatively, E. coli K1
interaction with FccRIa activates non-microbicidal mechanisms
for the bacterial survival in MØ. Our studies have demonstrated
that E. coli K1 infected MØ also exhibit increased expression of
gp96, a known chaperone for TLR2 and TLR4 [28]. These
interactions may also induce effector proteins into MØ by E. coli
K1 that eventually are responsible for the control of macrophage
environment. Further studies are in progress to examine these
possibilities. As cytokines are known to modulate MØ microbicidal
activity, it is also possible that the surface expression of TLRs and
CR3 could be controlled by the circulating cytokines in E. coli K1
infection. Of note, we have demonstrated that IL-10 administra-
tion suppressed the expression of FccRI and enhanced the
expression of TLR4 and CR3, which in turn prevented the
survival of E. coli K1 in MØ [61]. In contrast, for several other
pathogens, circulating IL-10 supports intracellular replication,
indicating that E. coli K1 pathogenesis is distinct from that induced
by other bacterial pathogens [62].
Previous studies have shown that the cytoplasmic (CY) domain of
FccRIa plays an important role in phagocytosis and antigen
presentation [63]. However, lack of the CY domain neither alters
the association of c-chain with FccRIa nor influences the tyrosine
phosphorylation of c-chain in response to receptor specific cross-
were transferred to a nitrocellulose and immunoblotted with anti-Myc antibodies. In separate experiments, the bound proteins were blotted with
anti-FccRIa antibodies (D). Purified Myc-FccRIa (5 and 10 mg) or BSA (10 mg) were incubated with OmpA+ E. coli separately, washed and then added
to COS-1 cells. Total cell bound and intracellular bacteria were determined (E). Binding and invasion assays were performed at least three times in
triplicate and the data represent mean 6 SD. The increase or decrease in binding or invasion of E. coli was statistically significant compared to
controls, *p or
$p,0.001 by Student’s t test.
doi:10.1371/journal.ppat.1001203.g004
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binding to FccRIa did not induce the association of c-chain despite
thepresenceoftheCYdomain.Thisbindingalsoinducedadifferent
tyrosine phosphorylation response in MØ. Therefore, the CY
domain of FccRIa induces signaling events independent of c-chain
during the invasion of E. coli K1. Similarly, Qin et al demonstrated
thattheCYdomaininducesdifferentgeneexpressioninmurineMØ
compared to MØ stably transfected with CY-deleted FccRIa [64].
Alteration of signal transduction pathways to impair FccR-mediated
phagocytosis has also been observed in HIV infected MØ, which
have downregulated the expression of the c-subunit [65]. Moreover,
direct interaction of periplakin with the CY domain of human
Figure 5. E. coli K1 binds to FccRIa via OmpA and induces a distinct signaling. (A) OmpA2 E. coli were coated with IgG2a for 1 h on ice,
washed and then added to COS-1 cells pre-treated with cytochalasin D. After one hour of incubation, the cells were washed and OmpA+ E. coli were
added at an MOI of 10 and 100. The cells were incubated for 10 min, washed, and the bound OmpA2 E. coli enumerated as described in Materials
and Methods. (B) Peritoneal MØ pre-treated with cytochalasin D were incubated with FITC-IgG2a for 30 min, washed, and further incubated with
OmpA+ or OmpA2 E. coli at an MOI of 10 or 100 for 10 min. The cells were washed and subjected to flow cytometry to determine the bound levels of
IgG2a. Cells without the addition of IgG2a were used as a control. (C) Immunoprecipitation of total cell lysates obtained from RAW 264.7 cells infected
with OmpA+ E. coli, OmpA2 E. coli or Zymosan with anti- FccRI antibody was followed by Western blotting with antibodies to c-chain or FccRI. (D)
Total cell lysates of RAW 264.7 cells infected with OmpA+ or OmpA2 E. coli were subjected to Western blotting with anti-phospho-tyrosine
antibodies. Competitive inhibition studies were performed at least four times in triplicate and the data represent mean 6 SD. The decrease in the
number of bacteria attached to COS-1 cells or MFI was statistically significant compared to IgG2a coated OmpA2 E. coli,* p ,0.001 by Student’s t test.
doi:10.1371/journal.ppat.1001203.g005
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2/2 mice are resistant to E. coli K1 induced meningitis. (A) Wild type (WT) and FccRIa
2/2 mice were infected intranasally at
post-natal day 3 with 10
3 CFU of E. coli K1. At various time points blood was collected, dilutions made, and bacteria enumerated by plating on agar
containing antibiotics. (B) Cerebrospinal fluid samples from experimental and control animals were collected and inoculated into LB broth containing
antibiotics and incubated overnight at 37uC. Positive cultures indicate the occurrence of meningitis. (C and D) TNF-a and IL-10 concentrations in the
blood of WT and FccRIa
2/2 animals infected with E. coli were measured by ELISA. (E) Blood-brain barrier leakage in infected animals was measured by
Evans blue extravasation method as described in Materials and Methods. (F) The bacterial load in the brains of infected animals was determined by
plating brain homogenates on agar containing antibiotics. (G) Brain halves from experimental and control animals were fixed, paraffin embedded,
sectioned and stained with H & E. Cortex and meninges showed severe inflammation (black arrow) along with apoptosis of neurons (yellow arrow) in
the brains of WT infected mice. White matter revealed increased cellularity due to inflammatory exudate (black arrow). Neutrophil infiltration (black
arrow) and apoptosis of neurons (yellow arrow) were observed in hippocampus. On the contrary, no such pathological changes were seen in the
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be noted that there are significant differences in the cytoplasmic
regions of human and murine FccRIa. However, our data
demonstrate that the interaction of OmpA induced a similar
response in both human and murine MØ. In summary, our studies
provide the first evidence that a bacterial protein interacts directly
with FccRIa in order to bind to and enter MØ and manipulates the
intracellular signaling for bacterial survival and multiplication. The
new repertoire of interaction also suggests that MØ function may be
manipulated by targeting additional epitopes without activating MØ
microbicidal function. This strategy will be useful for devising novel
methods of therapy for other diseases involving FccRIa in addition
to neonatal E. coli K1 meningitis.
Materials and Methods
Ethics statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The
protocol was approved by the Institutional Animal care and Use
Committee (IACUC) of The Saban Research Institute of
Childrens Hospital Los Angeles (Permit number: A3276-01). All
surgery was performed under sodium pentobarbital anesthesia,
and all efforts were made to minimize suffering.
Bacteria
E. coli E44, a rifampin-resistant mutant of E. coli K1 strain RS
218 (serotype O18:K1:H7), has been isolated from the cerebro-
spinal fluid of a neonate with meningitis and invades human brain
microvascular endothelial cells (HBMEC) [34]. E91, a derivative
of E44 in which ompA gene is disrupted (designated as OmpA2 E.
coli) and HB101 (a laboratory E. coli strain that expresses K-12
capsular polysaccharide) are noninvasive in HBMEC [34]. Group
B streptococcus type III strain COH-1 used in these studies was
provided by Dr. Craig Rubens of Seattle Children’s Hospital,
Seattle [67]. All bacteria were grown in brain heart infusion broth
with appropriate antibiotics as necessary. Bacterial media were
purchased from Difco laboratories (Detroit, MI).
Cell culture and reagents
Murine MØ cell line RAW 264.7, human macrophage like cells,
THP-1 and COS-1 cells were obtained from American Type Culture
Collection (Manassas, VA). COS-1 cells were stably transfected with
cDNA encoding human FccRIa, a mutant form of FccRIa
containing a stop codon after first amino acid of the cytoplasmic
domain (Lys
315RStop 315) (FccRI-CT), or with human FccRII [67].
Anti- FccRI (blocks the binding of Fc-portion of IgG to FccRI), anti-
CD11b, anti-CD32, anti-MR, anti-TLR2, anti-TLR4 and anti-Myc
antibodies were obtained from Cell signaling. Purified IgG2a and
FITC-IgG2a were obtained from Sigma (St. Louis, MO). Anti-gp96
antibody was raised in our lab as previously described [34,68]. Anti-
phospho-tyrosine antibody (4G10) was obtained from BD Sciences
and all secondary antibodies coupled to various fluorophores were
obtained from Bio-Rad Labs (Hercules, CA).
Bacterial invasion assays
Confluent MØ monolayers in 24-well plates were incubated
with 1610
6 E. coli K1 (multiplicity of infection of 10) in
experimental medium (1:1 mixture of Ham’s F-12 and M-199
containing 5% heat-inactivated fetal bovine serum) for 60umin at
37uC, whereas COS-1 cell monolayers were infected with E. coli
K1 at an MOI of 100 for 1.5 h. The monolayers were washed
three times with RPMI 1640uand further incubated in experi-
mental medium containing gentamicin (100 mg/ml) for 1 h to kill
extracellular bacteria. The monolayers were washed again and
lysed with 0.5% Triton X-100. The intracellular bacteria were
enumerated by plating on sheep blood agar. In duplicate
experiments, the total cell associated bacteria were determined
as described for invasion except that the gentamicin step was
omitted.
Generation of FccRIa
2 and CR3
2 RAW 264.7 cells
SureSilencing shRNA plasmids to mouse FccRIa and CR3
(CD11b) in the pGeneClip Neomycin Vector were obtained from
Super Array Inc., (Frederick, MD). RAW 264.7 cells were
transfected with shRNA plasmids using Lipofectamine 2000 and
later selected for G418 resistant colonies.
Biotinylation of MØ membrane proteins
The cell surface proteins of THP-1 cells differentiated into MØ
(THP-M) and RAW 264.7 cells were biotinylated by adding to
0.1 M sodium bicarbonate buffer (pH 8.0) containing 0.5 mg/ml
NHS-LC-Biotin (Pierce Co, Rockford, IL) at a final protein
concentration of 2 mg/ml in tissue culture flasks. The flasks were
incubated on ice for 1 h, the cells were extensively washed with
ice-cold PBS and solubilized in 5% Triton X-100 in PBS. Total
membranes from the cells were isolated following extensive dialysis
against PBS and then were concentrated using Centricon tubes
(Millipore, Bedford, MA; 10-kDa cut-off). Biotinylated proteins (2–
5 mg) were incubated with various bacteria from a 5-ml overnight
culture in a volume of 0.5 ml at 37uC on a rotator for 1 h. The
bacteria were then centrifuged and the pellets were washed three
times with PBS containing 0.1% Triton X-100. After a final wash,
the bound proteins were released with Laemmli buffer in the
presence of b-mercapto-ethanol and analyzed by SDS-PAGE. The
separated proteins were transferred to nitrocellulose and immuno-
blotted with streptavidin coupled to peroxidase. The protein bands
were visualized by ECL reagent (Amersham Biosciences, Piscat-
away, NJ).
RNA isolation and RT-PCR
Total RNA was isolated from various transfected RAW 267.4
cells with TRIZOL-LS-reagent (Gibco BRL, Gaithersburg, MD)
and quantified using a nanodrop machine. RT-PCR was
performed using the following primer sequences: FccRIa
(321 bp) FP 59-TCCTTCTGGAAAATACTGACC-39 and RP
59 GTTTGCTGTGGTTTGAGACC-39; TLR2 (459 bp) FP 59-
TGAGAGTGGGAAATA TGGAC-39;R P5 9-CCTGGCTCTA-
TAACTCTGTC-39; TLR4 (506 bp) FP 59- TGGAT ACG-
TTTCCTTATAAG-39 and RP 59-GAAATGGAGGCACC-
CCTTC- 39; GAPDH (479 bp), FP 59-CACAGTCCATGCCAT-
CACTG-39 and RP 59- TACTCCTTGGAG GCCATGTG -39.
Negative control assays without primers were performed in
parallel for every reaction. The amplified products were separated
on a 1% agarose gel and were stained with ethidium bromide.
brains of FccRIa
2/2 animals infected with E. coli K1. Data represent cumulative values from 15 animals in each group performed three times
independently. Statistical analysis was done by Student’s t test and Chi Square test. *p,0.001 indicates a significant difference compared with WT
infected animals. Scale bars, 20 mM.
doi:10.1371/journal.ppat.1001203.g006
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2/2 mice upon infection with E. coli K1. (A)
Peritoneal MØ from infected WT and FccRIa
2/2 mice were isolated, stained with antibodies to FccRI, TLR2, TLR4 and CR3, and then subjected to flow
cytometry. Data are presented after subtracting the mean fluorescence intensity (MFI) of isotype-matched control. (B) The production of NO by MØ
infected with E. coli K1 isolated from WT and FccRIa
2/2 mice was measured as nitrite by the Griess method. (C and D) Bone marrow derived MØ
(BMDMs) from FccRIa
2/2 mice were transfected with FccRIa, FccRIa-CT or FccRII and used for E. coli K1 binding and invasion assays. (E) Flow
cytometry of FccRIa
2/2BMDMs transfected with FccR constructs were infected with E. coli K1 for 6 h, washed and then subjected to flow cytometry
after staining with antibodies to FccRI, TLR2, TLR4, or CR3. MFI values for control-uninfected cells were subtracted from the values of infected cells
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Expression of FccRI, CR3, TLR2 and TLR4 was detected by
staining with appropriate FITC-, phycoerythrin (PE)-, PE-CY5.5-,
or allophycocyanin (APC)-coupled mouse monoclonal antibodies
(eBiosciences, San Diego, CA). Cells were first pre-incubated for
20 min with IgG blocking buffer to mask non-specific binding sites
and then further incubated with the indicated antibodies or an
isotype control antibody for 30 min at 4uC. The cells were
subsequently washed three times with PBS containing 2% FBS
and fixed with BD Cytofix (BD Biosciences). Cells were then
analyzed by four-color flow cytometry using FACS calibur Cell
Quest Pro software (BD Biosciences, San Jose, CA). Side and
forward scatter parameters for which F4/480 was used as a MØ-
gating marker, which formed the collection gate and at least 5000
events within this gate were collected for analysis.
Depletion of MØ
Newborn C57BL/6 mice were injected intraperitoneally with
(20-mg/Kg body weight) a-carrageenan (Sigma, St. Louis, MO)
on days 1, 2 and 3 before infecting with E. coli. In control groups,
mice were treated with equal volumes of saline.
Newborn mouse model of meningitis
Three-day old mice were randomly divided into various groups
and infected intranasally with 10
3 CFU of bacteria. Control mice
received pyrogen free saline through the same route. Blood was
collected from the tail or facial vein at designated times post-
infection and plated on LB agar containing rifampicin to assess
bacteremia and level of infection. CSF samples were collected
aseptically under anesthesia by cisternal puncture and directly
inoculated into broth containing antibiotics. Mice were perfused
intracardially with 0.9 % saline to remove blood and contami-
nating intravascular leukocytes. Brains were aseptically removed
and homogenized in sterile PBS. Bacterial counts in all tissues
were determined by plating ten-fold serial dilutions on rifampicin
LB agar plates. Growth of E. coli in rifampicin containing LB broth
from the CSF samples was considered positive for meningitis [28].
Characterization of liver and spleen leukocytes
Determination of leukocytes in livers and spleens of untreated
and carrageenan treated mice was done using flow cytometry [61].
PMNs were identified by staining with anti-Ly6-G (GR-1) followed
by goat anti-rat- phycoerythrin (PE). CD4
+ and CD8
+ T
lymphocytes were stained with rat anti-mouse-CD4 followed by
goat anti-rat-PE and anti-CD8-FITC. DCs were stained with APC
conjugated anti-CD11c antibody. B lymphocytes were detected by
staining with anti-CD45R (B220)-FITC. Flow cytometry was
performed on a FACScan instrument (BD Biosciences, CA) and
the data were analyzed with Cell Quest Software.
Immunoprecipitation and Western blotting
Total cell lysates of RAW 264.7 cells infected with bacteria for
varying time periods were centrifuged at 16,000 X g for 20 min at
4uC. The supernatants were collected and the protein contents
determined. For immunoprecipitation studies, 300–500 mgo f
protein was incubated with the appropriate antibody overnight
at 4uC, washed and further incubated for 1 h with protein A-
agarose. The immune complexes were washed four times with cell
lysate buffer and the proteins bound to agarose were eluted in SDS
sample buffer for further analysis by Western blotting. Portions of
the cell lysates were subjected to electrophoresis on a 10% SDS-
polyacrylamide electrophoresis gel. The proteins were transferred
to a nitrocellulose membrane, which was then blocked with 5%
bovine serum albumin (BSA) in Tris-buffered saline containing
0.05% Tween 20 (TBST) for 2 h at room temperature. The blot
was then incubated with the primary antibody overnight at 4uCi n
5% BSA/TBST. The blot was washed with TBST and further
incubated with the horseradish peroxidase-conjugated secondary
antibody for 1 h at room temperature. Subsequently, the blot was
washed four times with TBST for 1 h, developed with SuperSignal
chemiluminescence reagent, and exposed to x-ray film to visualize
the proteins.
Transmission electron microscopy
RAW 264.7 cells were incubated with E. coli K1 at an MOI of
10 for varying times, washed and then fixed with 2%
glutaraldehyde in 0.1 M cacodylate buffer, pH 7.1. All samples
were washed three times in 0.1 M cacodylate buffer for 15 minutes
each. The cells were then post-fixed for 20 minutes in 1% osmium
tetroxide at 4uC followed by addition of EtOH (60%). Samples
were dehydrated through 70, 80, 95, and 100% EtOH (two times,
15 min each), then into propylene oxide (two time, 15 min each),
and into a 1:1 propylene oxide/Eponate, left overnight, capped, at
room temperature. The propylene oxide/Eponate mixture was
decanted off and replaced with 100% Eponate mixture. The
samples were polymerized at 70uC for 48 h. Thin sections
(,80 nm) were cut using a diamond knife, mounted on un-coated
300 mesh copper grids and stained with 5% uranyl acetate for
20 min. Photographs were take with a transmission electron
microscope (JEOL JEM 2100 LaB6) equipped with a Gatan Ultra
Scan 1000 CCD camera.
Competitive binding assays
COS-1 cells were grown in 24-well tissue culture plate to
confluence and then treated with 0.5 mg/ml of cytochalasin D for
30 minprior toaddition ofbacteria. OmpA2 E.coli wereincubated
withanti-S-fimbria antibodyfor 1 h on ice, washed,and then added
to the COS-1 monolayers at an MOIof 100 for 1 h. OmpA2 E. coli
alone infected monolayers served as controls in these experiments.
The monolayers were then washed to remove unbound bacteria
and incubated with OmpA+ E. coli at an MOI of 10 and 100 for
10 min, washed the monolayers, and then dissolved in 150 mlo f
PBS containing 0.3% Triton X-100. Serial dilutions were made and
plated on agar containing tetracycline (12.5 mg/ml) in which only
OmpA2 E. coli grow. The number of CFU was counted and
determined the percent displacement by OmpA+ E. coli. In some
experiments, FITC-IgG2a (1 mg) was incubated with cytochalasin-
D treated peritoneal MØ while rotating the test tube at a low speed
for 30 min and washed to remove unbound IgG. Various inocula of
OmpA+ E. coli or OmpA2 E. coli were added to the cells and
incubated for 10 min, washed and the bound FITC-IgG was
determined by flow cytometry.
Differential staining of E. coli K1
RAW 264.7 cells were grown in eight-well chamber slides and
infected with E. coli K1 as described above. The monolayers were
and then graphed. (F) NO production was also determined in FccRI
2/2 BMDMs transfected with FccRIa, FccRIa-CT or FccRII at various times post-
infection. All experiments were performed three times in triplicate. The increase or decrease in the surface expression was statistically significant by
Student’s t test, *p,0.001.
doi:10.1371/journal.ppat.1001203.g007
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+/+ MØ into FccRIa
2/2 mice restored the susceptibility to E. coli K1 meningitis. FccRIa
2/2 mice
were reconstituted with FccRIa
+/+ MØ by intraperitoneal injection as described in Materials and Methods. Blood was withdrawn at various time points
and bacteremia levels enumerated by plating the serial dilutions on agar containing antibiotics (A). Cerebrospinal fluid obtained from the same
animals as described in A were directly inoculated into LB broth containing antibiotics. Positive broth cultures were considered positive for the
occurrence of meningitis (B). In addition, blood brain barrier leakage (C) and brain bacterial load (D) were determined as described in Materials and
Methods. Increase in these parameters in FccRIa
+/+ MØ reconstituted mice was statistically significant compared with FccRIa
2/2 MØ reconstituted
animals, *p,0.001 by Student’s t test. Results are representative of four independent experiments with 12 animals per group. Data represent mean 6
SE.
doi:10.1371/journal.ppat.1001203.g008
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10 min at room temperature. Subsequently, anti-S-fimbria
antibody (1:1000 dilution) was added to the cells and incubated
for 1 h at room temperature. The cells were then washed with PBS
and incubated with secondary antibodies conjugated to FITC for
30 min at room temperature. The monolayers were washed four
times with PBS and incubated with excess amounts of secondary
antibody coupled to horseradish peroxidase for 1 h at RT to block
the external primary antibody sites. After thorough washing of the
cells, the monolayers were permeabilized with 5% normal goat
serum in phosphate-buffered saline containing 1% Triton X-100
(NGS/PBST) for 30 min. The cells were again incubated with
anti-S-fimbria antibody for 1 h in Triton/NGS/PBST buffer,
washed and further incubated with secondary antibody coupled to
Cy3 for 30 min. The cells were washed again, the chambers
removed, and the slides mounted in Vectashield (Vector
Laboratories) anti-fade solution containing 49, 6-diamidino-2-
phenylindole. Cells were viewed using a Leica (Wetzlar, Germany)
DMRA microscope with Plan-apochromat 640/1.25 NA and
663/1.40 NA oil immersion objective lenses. Image acquisition
was with a SkyVision-2/VDS digital CCD (12-bit, 128061024
pixel) camera in unbinned or 262-binned models into EasyFISH
software, saved as 16-bit monochrome, and merged as 24-bit RGB
TIFF images (Applied Spectral Imaging Inc., Carlsbad, CA). The
images were assembled and labeled using Adobe PhotoShop 7.0.
Determination of the BBB leakage
BBB permeability was quantitatively evaluated by detection of
extravasated Evans blue dye [28]. Briefly, 2% Evans blue dye in
saline was injected intraperitoneally into infected or uninfected
mice and after 4 h, mice were deeply anesthetized with Nembutal
and transcardially perfused with PBS until colorless perfusion fluid
was obtained from the right atrium. Brains from infected animals
were harvested, weighed and homogenized. Tissue supernatant
was obtained by centrifugation and protein concentration was
determined. Evans blue intensity was determined on a microplate
reader at 550 nm. Calculations were based on external standards
dissolved in the same solvent. The amount of extravasated Evans
blue dye was quantified as micrograms per milligram protein.
Isolation of peritoneal MØ and adoptive transfer of MØ
Peritoneal MØ were isolated from mice according to the
method of Mittal et al [28,69,70]. Briefly, the mouse peritoneal
cavity was exposed carefully without disrupting blood vessels and
2–3 ml of RPMI was slowly injected. The lavage was collected and
cultured in tissue culture flasks for 2 h at 37uC under 5% CO2 to
allow adherence of MØ. Non-adherent cells were removed and
the flasks washed three times with Hanks’ solution. The adherent
cells were harvested from the flasks using a rubber policeman and
were resuspended in 10% FCS-RPMI 1640 medium. MØ were
then positively selected using Miltenyi biotech kit and percentage
purity examined by FACS analysis using F4/80 antibody, which
was .97%. Viability of MØ following interaction with bacteria
was assessed using an Annexin V kit (BD Biosciences, San Diego,
CA). Mouse bone marrow cells were isolated from the tibias and
femurs of 6- to 10-wk-old WT and FccRI
2/2 mice [71]. After
euthanasia of mice by CO2 asphyxiation, femurs were harvested
and bone marrow cells aseptically flushed from the marrow
cavities with ice-cold PBS. Cells were collected by centrifugation
and erythrocytes were lysed by resuspending in 0.15 M NH4Cl for
3–5 min. Celle were washed with PBS and resuspended in
complete DMEM medium supplemented with M-CSF (10 ng
ml
21) and IL-3 (10 ng ml
21), plated and allowed to differentiate
into MØ. After 5–7 days in culture, adherent MØ were washed
with PBS, scraped gently into suspension and counted. The purity
of the MØ was determined by flow cytometry using F4/80
antibody and found to be .95%. Fresh bone marrow derived MØ
(5610
6 cells) were transferred by intraperitoneal injection into
mice 6 h before infecting with E. coli K1.
Estimation of NO production
NO production was determined in MØ supernatants by a
modified Griess method as described earlier [28,72,73]. Briefly
nitrate was converted to nitrites with b-nicotinamide adenine
dinucleotide phosphate (NADPH, 1.25 mg ml
21) and nitrate
reductase followed by addition of Griess reagent. The reaction
mixture was incubated at room temperature for 20 min followed
by addition of TCA. Samples were centrifuged, clear supernatants
were collected and optical density was recorded at 550 nm. The
amounts of NO produced were determined by calibrating
standard curve using sodium nitrite.
Histopathology
Half of the brain was fixed in 10% buffered formalin, routinely
processed and embedded in paraffin. 4–5 mm sections were cut
using a Leica microtome and stained with hematoxylin and eosin
(H & E). Pictures were taken using a Zeiss Axiovert Microscope
connected to a JVC 3-chip color video camera and read by the
pathologist in a blinded fashion.
Cytokine assays
Cytokine (TNF-a, IL-1b, IL-6, IL-12 p70 and IL-10) levels in
sera from various animals were determined using Biosource
ELISA kits (Invitrogen, Carlsbad, CA) according to the manufac-
turer’s instructions.
Statistical analysis
For statistical analysis of the data, two tailed Fischer test,
Wilcoxon signed rank test and Student’s t-test were applied and p
value ,0.05 was considered statistically significant.
Supporting Information
Figure S1 Analysis of various cell types in MØ-depleted mice.
MØ were depleted in newborn mice by the administration of
carrageenan as described in Materials and Methods. Spleens and
livers were harvested, homogenized, and the cells in the
homogenates were subjected to flow cytometry for analysis of
neutrophils (A), dendritic cells (DCs) (B), CD4+ T cells (C), CD8+
T cells (D) and B cells (E).
Found at: doi:10.1371/journal.ppat.1001203.s001 (3.58 MB TIF)
Figure S2 Cytokine production in MØ-depleted mice infected
with E. coli K1. WT and MØ-depleted newborn mice were
infected with 10
3 CFU of E. coli K1 by intranasal instillation, blood
samples were collected at various times, and the concentrations of
IL-b (A), IL-6 (B), IFN-c (C) and IL-12 (D) determined by ELISA
as described in Materials and Methods. The data represent means
6 SD of three independent experiments with five animals in each
group. The decrease in the cytokines in MØ-depleted animals was
statistically significant compared to WT animals, *p,0.001 by
Student’s t test.
Found at: doi:10.1371/journal.ppat.1001203.s002 (2.54 MB TIF)
Figure S3 Bacteremia andcytokineslevelsinWTand FccRIa
2/2
mice infected with E. coli K1. (A) WT and FccRI
2/2 mice at day 3
were infected with E. coli K1, blood samples collected at various
times, dilutions made and plated on blood agar containing
antibiotics. The levels of IL-1b (B), IL-6 (C), IL-12 (D) in the blood
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SD of three separate experiments performed in triplicate with fifteen
animals in each group.
Found at: doi:10.1371/journal.ppat.1001203.s003 (1.28 MB TIF)
Figure S4 Bacterial load and the occurrence of meningitis in
newborn mice infected with Group B streptococcus. (A) WT and
FccRIa
2/2 mice at day 3 after birth were infected with 10
5 CFU
of GBS intranasally. Blood was collected at 24, 48 and 72 h post-
infection, dilutions were made, and plated on agar. (B) CSF
samples were collected aseptically by cisternal puncture and
inoculated directly into LB broth, and positive CSF cultures were
considered positive for the occurrence of meningitis. (C) At 72 h
post-infection brains were harvested and half of the brains were
homogenized in PBS, dilutions were made and plated on agar.
The data represent mean 6 SD of three separate experiments with
four animals each group.
Found at: doi:10.1371/journal.ppat.1001203.s004 (0.71 MB TIF)
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